MX2020006856A - Trombina secada por aspersion y metodos de uso y preparacion de trombina secada por aspersion. - Google Patents

Trombina secada por aspersion y metodos de uso y preparacion de trombina secada por aspersion.

Info

Publication number
MX2020006856A
MX2020006856A MX2020006856A MX2020006856A MX2020006856A MX 2020006856 A MX2020006856 A MX 2020006856A MX 2020006856 A MX2020006856 A MX 2020006856A MX 2020006856 A MX2020006856 A MX 2020006856A MX 2020006856 A MX2020006856 A MX 2020006856A
Authority
MX
Mexico
Prior art keywords
spray
methods
dried thrombin
thrombin
dried
Prior art date
Application number
MX2020006856A
Other languages
English (en)
Inventor
Alexander Wesley Scott
Paul Jeffrey Sanders
Alyssa Sanders
Adam Christopher Mercer
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of MX2020006856A publication Critical patent/MX2020006856A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/104—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se divulgan materiales de trombina secada por aspersión obtenidos a partir de soluciones de materia prima que comprenden menos del 5 % en peso de albúmina y excluyen la trehalosa u otros excipientes, así como los métodos de preparación de los materiales de trombina y los métodos para tratar heridas sangrantes. Los métodos de uso incluyen la aplicación tópica de trombina secada por aspersión reconstituida en un sitio de sangrado, opcionalmente junto con gelatina.
MX2020006856A 2017-12-29 2018-12-20 Trombina secada por aspersion y metodos de uso y preparacion de trombina secada por aspersion. MX2020006856A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762611963P 2017-12-29 2017-12-29
US201862771936P 2018-11-27 2018-11-27
PCT/US2018/066838 WO2019133440A1 (en) 2017-12-29 2018-12-20 Spray-dried thrombin and methods of using and making spray-dried thrombin

Publications (1)

Publication Number Publication Date
MX2020006856A true MX2020006856A (es) 2020-08-24

Family

ID=65024106

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020006856A MX2020006856A (es) 2017-12-29 2018-12-20 Trombina secada por aspersion y metodos de uso y preparacion de trombina secada por aspersion.

Country Status (11)

Country Link
US (1) US11583610B2 (es)
EP (1) EP3731885A1 (es)
JP (1) JP2021508507A (es)
KR (1) KR20200105680A (es)
CN (1) CN111787958A (es)
AU (1) AU2018396037A1 (es)
BR (1) BR112020011034A2 (es)
CA (1) CA3083064A1 (es)
MX (1) MX2020006856A (es)
SG (1) SG11202005231RA (es)
WO (1) WO2019133440A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023115427A1 (en) 2021-12-23 2023-06-29 Guangzhou Bioseal Biotech Co., Ltd. Spray dried thrombin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
DE19859611C2 (de) 1998-12-23 2003-07-03 Aventis Behring Gmbh Fibrinklebergranulat und Verfahren zu dessen Herstellung
US7572769B2 (en) 1998-12-23 2009-08-11 Csl Behring Gmbh Fibrin adhesive granulate and method for its preparation
MX345479B (es) 2010-06-01 2017-02-01 Baxter Int Inc * Proceso para elaborar composiciones hemostaticas secas y estables.
US9408945B2 (en) 2010-06-01 2016-08-09 Baxter International Inc. Process for making dry and stable hemostatic compositions
WO2011151384A1 (en) 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
US10159720B2 (en) * 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法

Also Published As

Publication number Publication date
WO2019133440A1 (en) 2019-07-04
CA3083064A1 (en) 2019-07-04
AU2018396037A1 (en) 2020-06-18
JP2021508507A (ja) 2021-03-11
BR112020011034A2 (pt) 2020-11-17
US11583610B2 (en) 2023-02-21
US20210379240A1 (en) 2021-12-09
EP3731885A1 (en) 2020-11-04
CN111787958A (zh) 2020-10-16
SG11202005231RA (en) 2020-07-29
KR20200105680A (ko) 2020-09-08

Similar Documents

Publication Publication Date Title
PH12018500810A1 (en) Antibody agents specific for human cd19 and uses thereof
MX2017004579A (es) Estructuras fibrosas solubles y metodos para fabricarlas.
MX2018002990A (es) Uso de la akkermansia pasteurizada para tratar trastornos metabolicos.
WO2015073587A3 (en) Synthetic membrane-receiver complexes
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
CA2900779C (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
WO2016210384A3 (en) Bacteria engineered to treat metabolic diseases
WO2016149501A3 (en) Modified therapeutic agents and compositions thereof
MX2016011841A (es) Composiciones topicas de corticosteroides.
WO2019040106A3 (en) COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES
TN2015000371A1 (en) Substituted imidazopyridazines
WO2016200614A3 (en) Bacteria engineered to treat diseases associated with hyperammonemia
PH12017500615B1 (en) Ophthalmic composition comprising cyclosporine and trehalose
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
MX2016009241A (es) Metodos para reducir el mal olor y las bacterias.
EA201890212A1 (ru) Новое применение сульфата декстрана
WO2016011324A3 (en) 5'-triphosphate oligoribonucleotides
ZA202104166B (en) Sulcardine administration for treatment of acute atrial fibrillation
EA201692518A2 (ru) Способы улучшения производительности миокарда у пациентов после операции фонтена с применением композиций уденафила
MX2016014245A (es) Composiciones para el cuidado de telas que comprenden polimeros de poliuretano, poliurea y/o poliuretanourea.
MX2017014084A (es) Formulaciones de deposito inyectables.
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
NZ764440A (en) Use of cell membrane-bound signaling factors
MX2015012720A (es) Sales basicas de adicion de nitroxolina y usos de las mismas.
MX2020000636A (es) Proteinas sinteticas y usos terapeuticos de las mismas.